tiprankstipranks
Trending News
More News >
GlaxoSmithKline (GSK)
NYSE:GSK
US Market
Advertisement

GlaxoSmithKline (GSK) Income Statement

Compare
5,131 Followers

GlaxoSmithKline Income Statement

Last quarter (Q3 2025), GlaxoSmithKline's total revenue was £273.62B, an increase of 3315.11% from the same quarter last year. In Q3, GlaxoSmithKline's net income was £11.61B. See GlaxoSmithKline’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 31.38B£ 30.33B£ 29.32B£ 24.70B£ 24.35B
Gross Profit
£ 22.33B£ 21.76B£ 19.77B£ 16.53B£ 16.43B
Operating Expenses
£ 18.31B£ 15.02B£ 13.34B£ 12.18B£ 10.45B
Depreciation and Amortization
£ 2.55B£ 2.29B£ 2.15B£ 2.12B£ 2.05B
EBITDA
£ 6.67B£ 9.08B£ 8.60B£ 6.49B£ 8.07B
Operating Income
£ 4.02B£ 6.75B£ 6.43B£ 4.36B£ 5.98B
Other Income/Expenses
£ -544.00M£ -681.00M£ -805.00M£ -758.00M£ -809.00M
Pretax Income
£ 3.48B£ 6.06B£ 5.63B£ 3.60B£ 5.17B
Net Income
£ 2.58B£ 4.93B£ 14.96B£ 4.38B£ 5.75B
Per Share Metrics
Basic EPS
£ 1.26£ 2.44£ 2.44£ 2.74£ 2.88
Diluted EPS
£ 1.24£ 2.40£ 2.40£ 2.70£ 2.86
Weighted Average Shares Outstanding
2.04B 2.03B 2.01B 1.60B 1.99B
Weighted Average Shares Outstanding (Diluted)
2.07B 2.06B 2.04B 1.62B 2.02B
Currency in GBP

GlaxoSmithKline Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis